November 16, 2022


Image from Adobe Stock
Your Career | FREE
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

A boost in the middle

Faculty development leaders search for new ways to help mid-career hospitalists stay inspired and pursue their passions.

Tracheostomy tube shortage

The FDA alerted clinicians about the need to reuse tracheostomy tubes and to caution patients about decreased effectiveness of pre-exposure prophylaxis against COVID-19, among other recent actions.

Algorithm for HF risk stratification in the ED associated with better 30-day outcomes

A trial in Ontario used a point-of-care algorithm to determine whether patients seen in the ED for acute heart failure (HF) should be discharged directly from the ED or after up to three days of observation, followed by transitional care in a heart failure clinic, or be admitted for inpatient care.

High-intensity medical therapy at HF discharge reduced readmissions, death

Researchers stopped the STRONG-HF randomized trial early due to greater than expected differences in outcomes between patients who received rapid up-titration of guideline-directed medical therapy under strict follow-up and those who received usual care.

Home hospital care as effective for respiratory diseases as other conditions, study finds

Among patients requiring acute care for an exacerbation of asthma or chronic obstructive pulmonary disease or non-COVID-19 pneumonia who were treated at home, 96% completed their full admission at home, according to a retrospective analysis from one health system.

Coronavirus | FREE
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

New studies assess effects of anticoagulation during, after COVID-19

Use of intermediate, full-dose, or prophylactic anticoagulation in COVID-19 inpatients wasn't associated with any difference in in-hospital mortality in one study, while another found it was safe to discontinue anticoagulation after three months in patients with a COVID-19-associated clot.